Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
103.24
-2.91 (-2.74%)
Apr 25, 2025, 12:05 PM EDT - Market open
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
$1,632,670
Profits / Employee
$338,920
Market Cap
128.70B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GILD News
- 1 hour ago - Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance - Seeking Alpha
- 3 hours ago - Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 16 hours ago - Gilead Sciences, Inc. (GILD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 hours ago - Gilead reports quarterly profit, revenue flat as cancer sales slow - Reuters
- 20 hours ago - Gilead Sciences Announces First Quarter 2025 Financial Results - Business Wire
- 4 days ago - Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - Reuters
- 4 days ago - Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer - Business Wire
- 14 days ago - Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025 - Business Wire